These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 29113256)
1. NUDT expression is predictive of prognosis in patients with clear cell renal cell carcinoma. Wang Y; Wan F; Chang K; Lu X; Dai B; Ye D Oncol Lett; 2017 Nov; 14(5):6121-6128. PubMed ID: 29113256 [TBL] [Abstract][Full Text] [Related]
2. ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients. Lu X; Wan F; Zhang H; Shi G; Ye D Tumour Biol; 2016 Jan; 37(1):253-62. PubMed ID: 26198048 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of D-lactate dehydrogenase in patients with clear cell renal cell carcinoma. Wang Y; Li G; Wan F; Dai B; Ye D Oncol Lett; 2018 Jul; 16(1):866-874. PubMed ID: 29963157 [TBL] [Abstract][Full Text] [Related]
4. Identification and validation of soluble carrier family expression signature for predicting poor outcome of renal cell carcinoma. Fangning W; Chunguang M; Hailiang Z; Guohai S; Yao Z; Bo D; Yijun S; Yiping Z; Dingwei Y J Cancer; 2017; 8(11):2010-2017. PubMed ID: 28819401 [TBL] [Abstract][Full Text] [Related]
5. SOX2 and SOX12 are predictive of prognosis in patients with clear cell renal cell carcinoma. Gu W; Wang B; Wan F; Wu J; Lu X; Wang H; Zhu Y; Zhang H; Shi G; Dai B; Ye D Oncol Lett; 2018 Apr; 15(4):4564-4570. PubMed ID: 29541226 [TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma. Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients. Wan F; Wang H; Shen Y; Zhang H; Shi G; Zhu Y; Dai B; Ye D Oncotarget; 2015 Sep; 6(29):27378-87. PubMed ID: 26317545 [TBL] [Abstract][Full Text] [Related]
8. The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma. Xu WH; Shi SN; Wang J; Xu Y; Tian X; Wan FN; Cao DL; Qu YY; Zhang HL; Ye DW Med Sci Monit; 2019 Dec; 25():9458-9470. PubMed ID: 31825950 [TBL] [Abstract][Full Text] [Related]
9. NR1H3 Expression is a Prognostic Factor of Overall Survival for Patients with Muscle-Invasive Bladder Cancer. Wu J; Wan F; Sheng H; Shi G; Shen Y; Lin G; Dai B; Zhu Y; Ye D J Cancer; 2017; 8(5):852-860. PubMed ID: 28382148 [TBL] [Abstract][Full Text] [Related]
10. The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma. Zhou Y; Wang X; Zhang W; Liu H; Liu D; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X Front Oncol; 2021; 11():630706. PubMed ID: 33968730 [TBL] [Abstract][Full Text] [Related]
11. Forkhead-box series expression network is associated with outcome of clear-cell renal cell carcinoma. Jia Z; Wan F; Zhu Y; Shi G; Zhang H; Dai B; Ye D Oncol Lett; 2018 Jun; 15(6):8669-8680. PubMed ID: 29805604 [TBL] [Abstract][Full Text] [Related]
12. Decreased expression of TXNIP predicts poor prognosis in patients with clear cell renal cell carcinoma. Gao Y; Qi JC; Li X; Sun JP; Ji H; Li QH Oncol Lett; 2020 Jan; 19(1):763-770. PubMed ID: 31897192 [TBL] [Abstract][Full Text] [Related]
13. A Panel of Four-lncRNA Signature as a Potential Biomarker for Predicting Survival in Clear Cell Renal Cell Carcinoma. Liu H; Ye T; Yang X; Lv P; Wu X; Zhou H; Zeng J; Tang K; Ye Z J Cancer; 2020; 11(14):4274-4283. PubMed ID: 32368310 [TBL] [Abstract][Full Text] [Related]
14. Fatty Acid Synthase Correlates With Prognosis-Related Abdominal Adipose Distribution and Metabolic Disorders of Clear Cell Renal Cell Carcinoma. Xu W; Hu X; Anwaier A; Wang J; Liu W; Tian X; Zhu W; Ma C; Wan F; Shi G; Qu YY; Zhang H; Ye D Front Mol Biosci; 2020; 7():610229. PubMed ID: 33569391 [No Abstract] [Full Text] [Related]
15. Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis. Jiang HM; Wei JH; Zhang ZL; Fang Y; Zhou BF; Chen ZH; Lu J; Liao B; Zhou FJ; Luo JH; Chen W Int Urol Nephrol; 2016 Feb; 48(2):191-9. PubMed ID: 26589610 [TBL] [Abstract][Full Text] [Related]
16. FOXO4 and FOXD3 are predictive of prognosis in gastric carcinoma patients. Li J; Jiang Z; Han F; Liu S; Yuan X; Tong J Oncotarget; 2016 May; 7(18):25585-92. PubMed ID: 27027443 [TBL] [Abstract][Full Text] [Related]
17. Upregulation of lncRNA AGAP2-AS1 is an independent predictor of poor survival in patients with clear cell renal carcinoma. Gao L; Zhao A; Wang X Oncol Lett; 2020 Jun; 19(6):3993-4001. PubMed ID: 32382344 [TBL] [Abstract][Full Text] [Related]
18. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data. Zeng JH; Lu W; Liang L; Chen G; Lan HH; Liang XY; Zhu X J Transl Med; 2019 Aug; 17(1):281. PubMed ID: 31443717 [TBL] [Abstract][Full Text] [Related]
19. TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma. Glaser ZA; Love HD; Guo S; Gellert L; Chang SS; Herrell SD; Barocas DA; Penson DF; Cookson MS; Clark PE Urol Oncol; 2017 May; 35(5):286-293. PubMed ID: 28108243 [TBL] [Abstract][Full Text] [Related]
20. Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma. Wu J; Jin S; Gu W; Wan F; Zhang H; Shi G; Qu Y; Ye D Front Oncol; 2019; 9():152. PubMed ID: 30941304 [No Abstract] [Full Text] [Related] [Next] [New Search]